8-K
filed August 2, 2023, 7:59 PM ET
ticker CCRN
CIK 0001141103
earnings
confidence high
sentiment negative
materiality 0.75
Cross Country Healthcare Q2 revenue down 28% YoY; guides Q3 lower
CROSS COUNTRY HEALTHCARE INC
2023-Q2 EPS reported
$1.41
revenue$1,163,402,000
- Q2 revenue $540.7M (-28% YoY, -13% sequential); diluted EPS $0.60 vs $1.40 YoY.
- Adjusted EBITDA $44.4M (8.2% margin) vs $83.5M (11.1%) YoY; adjusted EPS $0.69 vs $1.40.
- Physician Staffing revenue +105% YoY to $45.3M; Nurse & Allied -32% to $495.4M.
- Repaid $73.9M term loan; repurchased 200K shares for $4.7M.
- Q3 guidance: revenue $440-450M; adjusted EPS $0.35-0.45; indicates continued decline.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
CROSS COUNTRY HEALTHCARE INC reported the quarter ended June 30, 2023 results: revenue $540.7 million, net income $21.3 million, EPS $0.60. Guidance initiated.
- Period
- the quarter ended June 30, 2023
- Revenue
- $540.7 million
- Net income
- $21.3 million
- EPS
- $0.60
- Guidance
- initiated
- Result
- reported results
Exact text from the filing
clients to optimize their workforce, and to further improve our profitability as we continue to penetrate the vendor neutral space.” Second quarter consolidated revenue was $540.7 million, a decrease of 28% year-over-year and 13% sequentially. Consolidated gross profit margin was 22.8%, up 20 basis points year-over-year and 40 basis points sequentially. Net
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
CROSS COUNTRY HEALTHCARE INC reported the six months ended June 30, 2023 results: revenue $1.2 billion, net income $50.8 million, EPS $1.41. Guidance initiated.
- Period
- the six months ended June 30, 2023
- Revenue
- $1.2 billion
- Net income
- $50.8 million
- EPS
- $1.41
- Guidance
- initiated
- Result
- reported results
Exact text from the filing
For the six months ended June 30, 2023, consolidated revenue was $1.2 billion, a decrease of 25% year-over-year.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.